Clinical Research, Medicine
Books, Journals, Abstracts & Communications, Courses
Profile Medical Doctor with 15+ years of progressive experience in the United States as a medical director, medical monitor, senior clinical coordinator, and research manager in both device and pharmaceutical settings. Focused on HIV, NASH, COVID-19, PBC, and oncology research, working extensively on therapy initiatives for research for a cure. Outstanding team leader and player. Developed (and implemented) protocols, standards of practice, rules/regulations. Expert in assessing and caring for physical and emotional needs of wide-ranging patient populations. Remain calm and focused in the most urgent of circumstances. Personable with all patients and staff; go out of the way to ensure their comfort. Naturally meticulous, never take shortcuts, continually prepared for all scenarios.
Signature Strengths Deep Medical Knowledge – Medical Monitoring - Clinical Research & Analysis - Patient Evaluations - Patient Relationship Management - Staff Management - Pharmacovigilance - Creating Testing Protocols - Partnering with Staff, Vendors & Physicians - Research & Medical Documentation - Drafting & Presenting Reports - Multitasking - Project Management - Study Set-up - Government Compliance: HIPPA, OSHA, FDA, IRB (Institutional Review Board), IBC (Institutional Biosafety Committee) - Document Specialist - Strong Psychosocial Skills - Well Organized
Education Clinical Research Coordinator Certification, 2009
Association of Clinical Research ProfessionalsInternal Medicine Residency, 2000 – 2005
Department of Internal Medicine IV.
Hospital Clínico “San Carlos” – Universidad Complutense de Madrid (Spain)MD, Medicine and Surgery, 1999
Facultad de Medicina. Universidad de Granada. Granada (Spain)Professional Experience Summary of Experience and Skills
- Managed clinical studies on HIV, NASH, and Oncology fields.
- Medical Monitoring for phase I and II studies.
- Developed innovative clinical study designs for review and discussion.
- Developed consistent language and criteria for informed consent forms, protocols, and case report forms for phase I, II and III studies.
- Reviewed and/or write additional medical documentation and/or provide medical input as needed, e.g. protocol synopsis, safety monitoring plans, process documents, investigator brochures, or other relevant presentations or materials.
- Conduct ongoing reviews of medical/safety data.
- Collaborate with clinical operations to develop and implement the overall data quality.
- Contribute to the preparation of clinical protocols, study reports, IND, IB, NDA/CTD documents.
- Manage and create site SOP’s, CAPA’s, Note to File’s, Sponsor Discrepancies, IRB submissions, and other regulatory affairs.
- Manage and create site source documents, sponsor specific source documents, office forms, trainings, and other office matters.
- Collaborate with patient subjects on phase I, II, & III efficacy of controlled drugs
- Supervise clinical trials; orchestrate patient care and administrative duties.
- Educate patients regarding proper procedures and information needed pre-trial: appointments, medications, personal care, medical history, current and past treatments, consenting process.
- Monitor patients for safety concerns and side effects. Prepare patients for procedures; conduct vitals, ECGs, blood draws, medication prescriptions, STD and pregnancy testing, IV-line placement, daily venipunctures, lab value assessments. Counsel on diet and nutrition, performing wound care.
- Assess patient health and safety on experimental medications. Reporting SAEs and collecting medical records
- Outreach activities including subject recruitment, timely and adequate study enrollment.
- Providing leadership to junior clinical research coordinators
Clinical Research Gannex Pharma L.C. – Remote (USA)
Associate Medical Director. Sep 2021 – to date
Areas of specialty: NASH, PBC, HIV, COVID-19 and Oncology
Responsibilities: Cross-functional team membership and people management; Clinical Development Planning; CRO Management: function as the medical monitor of clinical studies and works closely with the CRO to achieve study timelines and goals
Studies
ASC41-201: Phase 2a/2b, double-blind, randomized, multicenter, placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41, a Thyroid Hormone Receptor 𝛃 Agonist, in Adults with Nonalcoholic Steatohepatitis (NASH).
ASC61-101: An Open-Label, Multicenter, Single-Arm Phase 1 Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61 in Subjects with Advanced Solid Tumors.
ASC42-103: A Phase 1, Open-label, Drug-Drug Interaction, Study to Evaluate the Effect of ASC42 on the Pharmacokinetics of Atorvastatin Tablets in Healthy Volunteers (HVs)
ASC43F-101: A Phase 1, Open-label, Single-dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ASC43F, a Fixed-dose Combination (FDC) Oral Tablet Containing ASC41, a THR beta Agonist and ASC42, an FXR Agonist in Healthy Subjects
ASC10-102: A Phase 1b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Efficacy and Pharmacokinetics of ASC10 tablets in Mild or Moderate COVID-19 patientsQuest Clinical Research– San Francisco (CA, USA)
Clinical Research Coordinator / Outreach Coordinator. Oct 2017 – Jul 2021
Areas of specialty: NASH, Oncology and HIV.
Responsibilities: Primary study coordinator for 9 sponsored industry clinical trials. Back-up coordinator for 4 sponsored industry clinical trials as well. Interfaced with diverse patient communities with a variety of disease severity. Maintained patient databases, screened patients for eligibility and obtained informed consent. Maintained IRB communications to ensure ethical standards are met. Interfaced with sponsors, vendors and database managers to ensure highest quality data is obtained. Coordinated and performed outreach activities in the community to assist with recruiting and enrollment in the diverse HIV, Oncology and NASH trials at Quest Clinical Research.
Studies
Viking Therapeutics VK2809: Phase 2b, randomized, double-blind, placebo-controlled, multi-center study to assess the efficacy, safety, and tolerability of VK2809 administered for 52 weeks followed by a 4-week off-drug phase in subjects with biopsy-proven non-alcoholic steatohepatitis (NASH) with fibrosis
Intercept's 747-303: Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multi-center Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis (NASH)
Tobira Therapeutics, Inc., Subsidiary of Allergan 3152-201-002: Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (NASH)
Tobira Therapeutics, Inc., subsidiary of Allergan 3152-301-002 - AURORA: A Phase 3, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (NASH)
Genfit GFT505-315-1: Multi-center, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis
Novartis CLJN452A2202: A randomized, double-blind, placebo-controlled, 3- part adaptive design, multi-center study to assess safety, tolerability and efficacy of tropifexor (LJN452) in patients with non-alcoholic steatohepatitis (NASH)
CytoDyn PRO 140_CD03: Multi-center Study to Assess the Clinical Safety and Treatment Strategy of Using PRO 140 SC as Long-Acting Single-Agent Maintenance Therapy for 48 Weeks in Virologically Suppressed Subjects with CCR5-tropic HIV-1 infection.
CytoDyn PRO 140_CD07_TNBC: Phase Ib/II Study of Leronlimab (PRO 140) Combined with Carboplatin in Patients with CCR5+ Metastatic Triple-Negative Breast Cancer (mTNBC)
CytoDyn PRO 140_CD07_TNBC_Compassionate Use: Compassionate Use Study of Leronlimab (PRO 140) in Combination with Treatment of Physician’s Choice in Patients with CCR5+ Metastatic Triple-Negative Breast Cancer (mTNBC)
CytoDyn PRO 140_CD09-Basket: Leronlimab (PRO 140) in Patients with CCR5+ Locally Advanced or Metastatic Solid Tumors
Taimed Biologics TMB-365-101: Phase 1, Randomized, Double-Blinded, Placebo-Controlled, Sequential Single Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of the Intravenous Administration TMB-365 in HIV-1 Infected Participants
AbbVie Inc. M19-939: Randomized, Double-blind, Placebo-controlled, Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of ABBV-181 in HIV-1 Infected Adults
Boehringer Ingelheim 1386-0004: Multi-centre, double-blind, parallel-group, randomized, placebo-controlled phase II study to investigate safety, tolerability, pharmacodynamics, and pharmacokinetics of different doses of orally administered BI 1467335 during a 12-week treatment period compared to placebo in patients with clinical evidence of NASH (completed)
Gilead Sciences, Inc. GS-US-384-1943: Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis (completed)
Gilead Sciences, Inc. GS-US-384-1944: Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH) (completed)
Novartis CLJN452A2202: Randomized, double-blind, placebo-controlled, 2- part, adaptive design, multi-center 12-week study to assess safety, tolerability, and efficacy of LJN452 in patients with non-alcoholic steatohepatitis (NASH) (completed)
Pfizer C1171002: Phase 2A, randomized, double-blind, placebo-controlled, dose-ranging, parallel-group study to evaluate safety, tolerability, and pharmacodynamics of PF-05221304 administered daily for 16-weeks to adult subjects with nonalcoholic fatty liver disease (NASH) (completed)
Intercept's 747-117: Phase 1, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis with Fibrosis (completed)
Paratek Pharmaceuticals PTK-0796-UUTI-17201: Randomized, Double-Blinded, Adaptive Phase 2 Study to Evaluate the Safety and Efficacy of oral Omadacycline and oral Nitrofurantoin in the treatment of female adults with cystitis (completed)
LaJolla’s LJ401-HH01: Phase 2 multi-center, randomized, placebo-controlled, single-blind study with LJPC-401 for the treatment of iron overload in adult patients with hereditary hemochromatosis (completed)
Janssen Research and Development NOPRODHPB0008: Collection of Immune Cells by Leukapheresis to Assess the Immune Cell Phenotype and Function in Patients with Chronic HIV Infection (completed)University of California, San Francisco – Movement Disorders and Neuromodulation Center – San Francisco (CA, USA)
Senior Clinical Research Coordinator / Outreach Coordinator. Dec 2016 – Oct 2017
Areas of specialty: dementiaResponsibilities: active coordination and management, ensuring that all aspects of the protocols are carried out appropriately, maintaining regulatory binders, ensuring CHR approval and compliance, subject recruitment, appropriate study testing, timely and adequate study enrollment, providing leadership to junior clinical research coordinators.
Studies
PCORI- Does Outpatient Palliative Care Improve Patient-Centered Outcomes in Parkinson's disease (PD): The purpose of this study was to improve outcomes for persons living with PD and their family caregivers. The investigators hypothesize that outpatient interdisciplinary palliative care will improve patient-centered outcomes for PD patients at high risk for poor outcomes.
NIH R01 - More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease: a two-center (University of Colorado, UCSF) community-based comparative effectiveness study of outpatient palliative care for PD and related disorders (progressive supra-nuclear palsy, corticobasal degeneration, multiple systems atrophy, Lewy Body Dementia. It utilized a randomized stepped-wedge design to compare patient and caregiver outcomes between usual care in the community versus usual care augmented by palliative training and telemedicine support to provide other resources (e.g. social work)University of Illinois at Chicago – Department of Nephrology – Chicago (IL, USA)
Research Assistant Professor. Aug 2012 – Jan 2016
Visiting Research Specialist. Oct 2010 – Aug 2012
Areas of specialty: hypertension
Responsibilities: Implementation of a clinical trial SPRINT (Systolic Blood Pressure Intervention Trial) including recruitment of participants, management of internal and external regulatory issues, and establishing record keeping systems in accordance to federal guidelines. Responsible for all research related activities including physical assessment, phlebotomy, blood pressure management, administration of questionnaires, and collection and transmission of clinical data and specimens. Performed cognitive testing such as MoCA, Digit Symbol Coding, Logical Memory, Hopkins Verbal Learning, Trail Making, Boston Naming, and Rey_O, Digit. To find out more about the SPRINT study, check out this article at the nytimes.
Rush Alzheimer’s Disease Center - Armour Academic Center – Chicago (IL, USA)
Research Study Coordinator.Aug 2009 – Jan 2010 Assistant Research Coordinator.May 2008 – Jul 2009 Research Coordinator.May 2008 – Jul 2009
Areas of specialty: dementia
Responsibilities:
- Planned activities of a portfolio of patient-oriented research studies and coordinating the workflow for a team of physicians, nurses, psychometricians, research assistants, phlebotomists, as needed for clinical and biologic data collection.
- Ensured adherence to all aspects of the studies protocol and mantains an organized, well-labeled file for studies material.
- Responsible of collection, completion and organization of research data ensuring integrity and completeness of data collected by various staff members.
- Had a thorough knowledge of the studies to ensure adherence to all aspects of the study protocol. Reviewed the protocol and other materials. Served as a resource person to the study staff, including clinicians and research assistants. Disseminated information about the studies to other professionals within the university and the community. Administered neuropsychological and physical function testing to participants, as required by the protocol, such as ADAS-cog, MMSE, CDR, Cantab, NPI, DAB.
- Assisted in the implementation of epidemiological and clinical trials studies (Memory and Aging Project Study) with Spanish and English speaking participants. Recruited study participants at numerous sites throughout the United States. Performed memory screenings and study information through community outreach at numerous health fairs. Presented educational seminars for caregivers of people suffering from Alzheimer’s disease, nurses and lay community members. Recruited study participants at numerous community locations including: retirement apartments, assisting living buildings, nursing homes and hospitals.Other Clinical Trials Experience Pharmacology Therapies in a Heart Failure Unit, 2000 - 2005
Department of Internal Medicine – Hospital Clínico San Carlos. Madrid (Spain)
- Oversaw a clinic that aimed to reduce hospital admissions due to arrhythmia caused by irregular patient usage of prescribed cardiac medications. Prescribed and monitored the use of arrhythmia drugs, treated anemia, avoided the use of NSAIDs, decreasing new incidences of heart failure as well as hospitalizations due to heart failure. Effective treatment of hypertension decreased the occurrence of left ventricular hypertrophy and cardiovascular mortality, as well as reduced the incidence of acute heart failure episodes.
- Longitudinal study of beta blockers in a geriatric inpatient population with heart failure. Discovered current patterns of beta blocker usage in hospitalized patients, concurrent to hospitalization as well as after. Evaluated factors involved in determining beta blocker dosage.Clinical and echocardiographic evolution of a Heart Failure Unit’s patients, 2000 - 2005
Department of Internal Medicine – Hospital Clínico San Carlos. Madrid (Spain)
- Study patients were enrolled in a program of lifestyle modification consisting of moderate sodium restriction, weight monitoring, adherence to rest and self-monitoring of physical symptoms. Clinical evaluations included 12-lead ECGs, vital sign and clinical laboratory results monitoring.
- The primary focus of this clinic was the control of cardiovascular risk factors such as hypertension, diabetes, metabolic syndrome, atherosclerotic disease and early detection of cardiac structural anomalies. This resulted in a significant reduction in emergency department visits and inpatient hospitalizations.Collaboration in Project e-CARDS and e-NEA CARDS, 2004
Editorial Científica Digital. Entorno Digital de Comunicación S.L.Medicine Hospital Mediterráneo, Almería (Spain) June 2019 – Aug 2019
Internal Medicine SpecialistBelen Policlinic, Cusco (Peru) Aug 2018 – Aug 2018
Internal Medicine SpecialistHospital Severo Ochoa (Leganés). Madrid (Spain), Jan 2006 – Jun 2006
Emergency Department PhysicianFundación-Hospital Alcorcón (Alcorcón). Madrid (Spain), Aug 2005 – Dec 2005
Emergency Department PhysicianHospital Clínico San Carlos. Madrid (Spain), 2000 - 2005
Internal Medicine Residency.
Formative rotations in the following specialties: Cardiology, Intensive Care, Neurology, Rheumatology, Radio diagnostic, Palliative care, Nephrology, Anesthesia and Resuscitation and an International Observership at Infectious Diseases and AIDS Department in Jackson Memorial Medical Center, Miami (Florida – EEUU), for 10 weeks in 2005.Certifications
- Collaborative Institutional Training Initiative (CITI Program)
- ICH Good Clinical Practice
- Data Privacy Training
- Research Aspects of HIPPA
- NIH: Protecting Human Research Participants
- IV / Blood Draw
- CPR / Basic Life Support
- ECG and Holter Certification
- Fibroscan operator training
- ICAO TI 4.2 / CFR 49 Subpart H / IATA 1.5: Dangerous Goods
- Shipping of Category A, Infectious Substance Affecting Humans, Category B, Biological Substance
- Transporting Dangerous Goods
- Annual Bloodborne Pathogens
- Hazard Communication Awareness Training
Community Development Centro San Bonifacio (Chicago, IL), July'08 – Jan 10
Vice-president.
Centro San Bonifacio's mission is to promote personal and collective self-development within the immigrant Hispanic community through concrete projects based on real needs related to health, education, solidarity and human rights.
http://www.sanbonifacio.org/Rush Medical Center – Memory Clinic (Chicago, IL), 2007 – 2010
Founder and Facilitator, “Sin Aviso” Support Group
Collaborate with medical personnel, family members, and caregivers to serve Alzheimer patients. Established critical Early On-Set educational support program for Spanish-speaking community with zero budget, generating funding through successful fundraisers and events.Community Health (Chicago), June’07 – Jan'10
Founder and health care provider of the Depression Support Group in Spanish.
CommunityHealth is Illinois' largest volunteer-based medical facility providing free care to the uninsured and undeserved, funded solely through private donations.
http://www.communityhealth.org/Publications
Books “Las Alergias” (Allergies), the author
Editorial Edimat Libros S.A. 2003.Several Chapters of Emergency Medicine, First Aid and Life Support Handbook’s
Escuela Madrileña de Socorrismo y Formación Sanitaria. S.Coop:• Conscience disorders.
• Respiratory Emergency.
• Acute Chest Pain.
• Acute Abdominal Pain.
• Ophthalmology emergency.
• Allergic Reactions. Anaphylaxis.
• Pharmacologic Intoxication.
• Ethanol Intoxication.
• Drugs Overdose.Journals Up Zhang WR1, Craven TE2, Malhotra R3, Cheung AK4, Chonchol M5, Drawz P6, Sarnak MJ7, Parikh CR8, Shlipak MG1, Ix JH9; SPRINT Research Group (Collaborator: Lopez Barrera N).
“Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study”.
Ann Intern Med. 2018 Nov 6;169(9):610-618.Berlowitz DR, Foy CG, Kazis LE, Bolin LP, Conroy MB, Fitzpatrick P, Gure TR, Kimmel PL, Kirchner K, Morisky DE, Newman J, Olney C, Oparil S, Pajewski NM, Powell J, Ramsey T, Simmons DL, Snyder J, Supiano MA, Weiner DE, Whittle J; SPRINT Research Group (Collaborator: Lopez Barrera N).
“Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes”.
N Engl J Med. 2017 Aug 24;377(8):733-744Rodriguez CJ, Still CH, Garcia KR, Wagenknecht L, White S, Bates JT, Del Cid MV, Lioudis M, Lopez Barrera N, Moreyra A, Punzi H, Ringer RJ, Cushman WC, Contreras G, Servilla K, Rocco M; SPRINT Research Group (Collaborator: Lopez Barrera N).
“Baseline blood pressure control in Hispanics: characteristics of Hispanics in the Systolic Blood Pressure Intervention Trial”.
J Clin Hypertens (Greenwich). 2017 Feb;19(2):116-125.Kurella Tamura M, Pajewski NM, Bryan RN, Weiner DE, Diamond M, Van Buren P, Taylor A, Beddhu S, Rosendorff C, Jahanian H, Zaharchuk G; SPRINT Study Research Group (Collaborator: Lopez Barrera N).
“Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults”.
Neurology. 2016 Feb 26Pajewski NM, Williamson JD, Applegate WB, Berlowitz DR, Bolin LP, Chertow GM, Krousel-Wood MA, Lopez-Barrera N, Powell JR, Roumie CL, Still C, Sink KM, Tang R, Wright CB, Supiano MA; SPRINT Study Research Group.
“Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial”.
J Gerontol A Biol Sci Med Sci. 2016 Jan 11.SPRINT Research Group (Collaborator: Lopez-Barrera N), Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT.
“A Randomized Trial of Intensive versus Standard Blood-Pressure Control”.
N Engl J Med. 2015 Nov 26;373(22):2103-16.Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC Jr, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Snyder JK, Williamson JD, Wright JT Jr, Whelton PK; (Collaborator: Lopez Barrera N).
“The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)”.
Clin Trials. 2014 Oct;11(5):532-46.López-Barrera N, Latorre González G, Medrano Izquierdo P, Escribano Gascón A y García García M.
Acute Infectious Meningitis. Tiempos Médicos.
Revista de Educación Médica Continuada.2005 Sep, N621-Pág.7.Martinez-Colubi M, Medrano Izquierdo P, Perez- Somarriba Moreno J, López-Barrera N y Ruiz Luna R.
Urinary Tract Infection in women.
Tiempos Médicos. Revista de Educación Médica Continuada.2005 Sep, N621-Pág.35. Martínez
Herreros B, Palacios G, López N, Garzarán A, Medrano P, Monzón S.
How to start investigating anaemia without an obvious cause?.
European Journal of Internal Medicine, Vol 14, Supl 1 2003, pg. 64.Palacios G, Herreros B, Monzón S, López N, Garzarán A, Ruiz I.
Risk factors for peripheral embolism in atrial fibrillation.
European Journal of Internal Medicine, Vol 14, Supl 1 2003, pg. 99.Merino P, Membrado S, Herreros B, López D, López N, Ruiz I.
Progressive Multifocal Leukoencefalopathy cases during nine years in Hospital Clinico San Carlos.
Revista clínica Española. Volumen 204, supplement 1, Sep 2004, pág.39.Merino P, Membrado S, Herreros B, López D, López N, Ruiz I.
Visceral Leishmaniasis: Clinical Data, epidemiology and diagnosis.
Revista clínica Española. Volumen 204, supplement 1, Sep 2004, pág.141.Garzarán A, López N, Herreros B, Palacios G, Muñoz I, Medrano P.
Pharmacologic Therapies in a Heart Failure Unit.
Revista clínica Española. Volumen 204, supplement 1, Sep 2004, pág.183.Herreros B, López N, Garzarán A, Palacios G, Muñoz I, López D.
Clinical evolution of a Heart failure unit´s patients.
Revista clínica Española. Volumen 204, supplement 1, Sep 2004, pág.183.Herreros B, López N, Garzarán A, Palacios G, Muñoz I, López D.
Description of a Heart failure unit´s working in an internal medicine department.
Revista clínica Española. Volumen 204, supplement 1, Sep 2004, pág.183.Herreros B, Muñoz I, López N, Palacios G, Merino P, López D, Jimeno A.
Left recurrent laryngeal nerve paralysis in a patient with apical pleuritis.
Revista clínica Española. Volumen 204, supplement 1, Sep 2004, pág.216.Herreros B, López N, Jimeno A, Medrano P, López D, Muñoz I, Pérez J.
Causes of changed diagnosis in the internal medicine ward.
Revista clínica Española. Volumen 204, supplement 1, Sep 2004, pág.351.Herreros B, López N, Medrano P, Jimeno A, López D, Muñoz I, Pérez J.
Concordance between diagnosis made in the emergency room and the ones made in the internal medicine ward.
Revista clínica Española. Volumen 204, supplement 1, Sep 2004, pág.352.Herreros B, Merino P, López D, Muñoz I, Palacios G, López N.
Descending aortitis: an uncommon form of presentation of giant cell arteritis.
Revista clínica Española. Volumen 204, supplement 1, Sep 2004, pág.395.Herreros B, De Blas B, López N, Palacios G, Garzarán A, Ruiz I.
Infectious colitis by non-common microorganisms.
Anales de Medicina Interna, Nº Extr, Oct 2003, pg. 51-52.López N, Herreros B, Palacios G, Garzarán A, Jimeno A, López D.
Prolonged fever and cervical spine pain.
Anales de Medicina Interna, Nº Extr, Oct 2003, pg. 51.Herreros B, Palacios G, López N, López D, Pérez J, Medrano P.
Evolutionary factors in aspiration pneumonias.
Anales de Medicina Interna, Nº Extr, Oct 2003, pg. 52.Herreros B, López N, Palacios G, López D, Pérez J, Medrano P.
Differences by sex in aspiration pheumonia.
Anales de Medicina Interna, Nº Extr, Oct 2003, pg. 52.Palacios G, Herreros B, Garzarán A, López N, Ruiz I, Medrano P.
Odinofagia and epigastralgia in a 28 year-old man with HIV.
Anales de Medicina Interna, Nº Extr, Oct 2003, pg. 57.Domínguez L, Herreros B, López N, Palacios G, Jimeno A, Santillana T.
Leucocytoclastic vasculitis in a solid tumor.
Anales de Medicina Interna, Nº Extr, Oct 2003, pg. 67-68.Herreros Ruiz-Valdepeñas B, Palacios García-Cervigón G, Garzarán Teijeiro A, López-Barrera N, Ruiz Ribera I y Tarquis Alfonso P.
Hypertension as a cardiovascular risk factor.
Tiempos Médicos. Revista de Educación Médica Continuada.2003 Enero,N596-Pág.7.Garzarán Teijeiro A, López-Barrera N, Ruiz Ribera I, Casado García J, Medrano Izquierdo P y Vergas García J.
Diabetes and cardiovascular effects.
Tiempos Médicos. Revista de Educación Médica Continuada.2003 Enero,N596-Pág.29.Garzarán A, López N, Herreros G, Medrano P, Palacios G, Varela MP.
What are the clinical differences between men and women in SAOS diagnosis?.
Revista Clínica Española, Vol 202, Supl 1, Nov 2002, pg. 25.Varela MP, López N, Garzarán A, Gómez A, Herreros B, Santillana T.
Types of clinical presentation in tuberculosis infection in an internal medicine department.
Revista Clínica Española, Vol 202, Supl 1, Nov 2002, pg. 141.Herreros B, Palacios G, Garzarán A, López N, Medrano P, Ruiz I, Varela MP.
Peripheral embolism y atrial fibrillation: predisposed factors and treatment importance.
Revista Clínica Española, Vol 202, Supl 1, Nov 2002, pg. 218.González-Castillo J, Herreros B, Cubo P, Palacios G, Muñoz S, López N.
Etiologic study of syncopes.
Revista Clínica Española, Vol 202, Supl 1, Nov 2002, pg. 231.Herreros B, Palacios G, Garzarán A, López N, Medrano P, Ruiz I.
Etiology of anaemia without an obvious cause in an internal medicine hospital.
Revista Clínica Española, Vol 202, Supl 1, Nov 2002, pg. 261.Gargantilla P, López N, Herreros B, Garzarán A, Palacios G, Gómez A.
Do we use appropriate doses of ACE Inhibitors?
Revista Clínica Española, Vol 202, Supl 1, Nov 2002, pg. 263.Mubark A, Herreros B, Palacios G, Garzarán A, López N, Díaz A.
Thyroid dysfunction and amiodarone.
Revista Clínica Española, Vol 202, Supl 1, Nov 2002, pg. 318.Herreros B, Santillana T, Gargantilla G, Varela MP, Palacios G, López N.
EEN Study of lung and cardiac pathology.
Archivos de Bronconeumología, Vol 38, Supl 2, jun. 2002, pg 108.Cabello Clotet N, López Barrera N, Ortuño Andériz F y Santillana López T.
Disabling back pain in a 53 year-old woman.
Revista Clínica Española. 2002 Mayo, Vol 202 ; N5-pag291.Fernández Alonso E, Gómez García A, López Barrera N, Palacios García-Cervigón G, Varela Jul P, Vergas García J y Villarroel González-Elipe P.
Urinary Tract Infections.
Tiempos Médicos. Revista de Educación Médica Continuada.2001 Noviembre,N584-pág.7.Gargantilla Madera P, Herreros Ruiz-Valdepeñas B, Garzarán Teijeiro A, López-Barrera N, Fernández Alonso E, Vergas García J y Pardo Redondo A.
Acute Infectious Gastroenteritis.
Tiempos Médicos. Revista de Educación Médica Continuada. 2001 Noviembre, N584-pág.35.López N, Garzarán A, Gargantilla P, Herreros B, Palacios G, Gómez A.
Syncope and electrocardiographic alterations in young patients.
Anales de Medicina Interna, Número extraordinario Nov 2001, pg. 40.Sopelana D, Herreros B, Mubarak A, Gómez A, Gargantilla P, González-Castillo J, López N, Garzarán A.
Young patient with tetraparesis in an emergency service.
Anales de Medicina Interna, Nº Extr Nov 2001, pg. 71-72.Varela MP, Gómez A, Gargantilla P, Herreros B, Casado J, López N, Lázaro C.
Clinical presentation of abdominal tuberculosis infection in an internal medicine department.
Anales de Medicina Interna, Nº Extr Nov 2001, pg. 64.Herreros B, Palacios G, Gargantilla P, Varela MP, López N, Garzaráno A.
Presentation of lung cancer in young patients.
Anales de Medicina Interna, Nº Extr Nov 2001, pg. 30.Abstracts and Communications Up Llanero M, Martinez M-Colubi M, Perez-Somarriba J, Medrano Izquierdo P, Ruiz Luna R, López N.
Digital arteriography as an important diagnostic test in Sneddon syndrome.
5th European Federation of Internal Medicine, Paris (France), 31 Agosto-3 Septiembre, 2005.Martínez M, Pérez-Somarriba J, Ruiz R, Medrano P, Latorre G, López N, García M, Escribano A, Manzano MC, Cinza R.
Postcardiotomy síndrome: A case that illustrates the process to arrive to a correct diagnosis.
5th European Federation of Internal Medicine, Paris (France), 31 Agosto-3 Septiembre, 2005.López N, Perez-Somarriba J, Martínez M, Ruiz R, Medrano P, Latorre G, López D, Jimeno A, Ruiz I, Palacios G.
Malaria infection in a 40-year-old woman as an example of a growing tropical diseases in our country (Spain).
5th European Federation of Internal Medicine, Paris (France), 31 Agosto-3 Septiembre, 2005.Merino P, Membrado S, Herreros B, López D, López N, Ruiz I.
Progressive Multifocal Leukoencefalopathy cases during nine years in Hospital Clinico San Carlos of Madrid.
27th World Congress of Internal Medicine, Granada (Spain), 26 Sep-1 Octubre.Merino P, Membrado S, Herreros B, López D, López N, Ruiz I.
Visceral Leishmaniasis: Clinical Data, epidemiology and diagnosis.
27th World Congress of Internal Medicine, Granada (Spain), 26 Sep-1 Octubre.Garzarán A, López N, Herreros B, Palacios G, Muñoz I, Medrano P.
Pharmacological Therapies in a heart failure unit.
27th World Congress of Internal Medicine, Granada (Spain), 26 Sep-1 Octubre.Herreros B, López N, Garzarán A, Palacios G, Muñoz I, López D.
Clinical evolution of patients in a heart failure unit.
27th World Congress of Internal Medicine, Granada (Spain), 26 Sep-1 Octubre.Herreros B, López N, Garzarán A, Palacios G, Muñoz I, López D.
Description of a Heart failure unit´s working in an internal medicine department.
27th World Congress of Internal Medicine, Granada (Spain), 26 Sep-1 Octubre.Herreros B, Muñoz I, López N, Palacios G, Merino P, López D, Jimeno A.
Left recurrent laryngeal nerve paralysis in a patient with apical pleuritis.
27th World Congress of Internal Medicine, Granada (Spain), 26 Sep-1 Octubre.Herreros B, López N, Jimeno A, Medrano P, López D, Muñoz I, Pérez J.
Causes of changed diagnosis in the internal medicine ward.
27th World Congress of Internal Medicine, Granada (Spain), 26 Sep-1 Octubre.Herreros B, López N, Medrano P, Jimeno A, López D, Muñoz I, Pérez J.
Concordance between diagnosis made in the emergency room and the ones made in the internal medicine ward.
27th World Congress of Internal Medicine, Granada (Spain), 26 Sep-1 Octubre.Herreros B, Merino P, López D, Muñoz I, Palacios G, López N.
Descending aortitis: an uncommon form of presentation of giant cell arteritis.
27th World Congress of Internal Medicine, Granada (Spain), 26 Sep-1 Octubre.Herreros B, Palacios G, López N, Garzarán A, Medrano P, Monzón S.
How to start investigating anaemia without an obvious cause?.
4th Congress of the European Federation of Internal Medicine, Berlin (Germany), 10-13 Sep 2003.Palacios G, Herreros B, Monzón S, López N, Garzarán A, Ruiz I.
Risk factors for peripheral embolism in atrial fibrillation.
4th Congress of the European Federation of Internal Medicine, Berlin (Germany), 10-13 Sep 2003.Herreros B, De Blas B, López N, Palacios G, Garzarán A, Ruiz I.
Infectious colitis by non-common microorganisms.
IX Congreso de la Soc. de Med. Interna de Madrid-Castilla La Mancha, Cuenca 23-25 Oct 2003.N, Herreros B, Palacios G, Garzarán A, Jimeno A, López N.
Prolonged fever and cervical spine pain.
IX Congreso de la Soc. de Med. Interna de Madrid-Castilla La Mancha, Cuenca 23-25 Oct 2003. LópezHerreros B, Palacios G, López N, López D, Pérez J, Medrano P.
Evolutionary factors in aspiration pneumonias.
IX Congreso de la Soc. de Med. Interna de Madrid-Castilla La Mancha, Cuenca 23-25 Oct 2003.Herreros B, López N, Palacios G, López D, Pérez J, Medrano P.
Differences by sex in aspiration pheumonia.
IX Congreso de la Soc. de Med. Interna de Madrid-Castilla La Mancha, Cuenca 23-25 Oct 2003.Palacios G, Herreros B, Garzarán A, López N, Ruiz I, Medrano P.
Odinofagia and epigastralgia in a 28 year-old man with HIV.
IX Congreso de la Soc. de Med. Interna de Madrid-Castilla La Mancha, Cuenca 23-25 Oct 2003.Domínguez L, Herreros B, López N, Palacios G, Jimeno A, Santillana T.
Leucocytoclastic vasculitis in a solid tumor.
IX Congreso de la Soc. de Med. Interna de Madrid-Castilla La Mancha, Cuenca 23-25 Oct 2003.López Barrera N, Herreros Ruiz Valdepeñas B, Gómez García AM, Garzarán Teijeiro A, Palacios García Cervigón GJ.
Patient with cervical spine pain and fever.
IX Reunión de la Sociedad de Madrid Castilla La Mancha de Medicina Interna, Universidad de Alcalá, Madrid, 31 Enero 2003.Garzarán A, López N, Herreros G, Medrano P, Palacios G, Varela MP.
What are the clinical differences between men and women in SAOS diagnosis?.
XXV Congreso Nacional de la SEMI, Madrid, 5-8 Nov 2002.Varela MP, López N, Garzarán A, Gómez A, Herreros B, Santillana T.
Types of clinical presentation in tuberculosis infection in an internal medicine department.
XXV Congreso Nacional de la SEMI, Madrid, 5-8 Nov 2002.Herreros B, Palacios G, Garzarán A, López N, Medrano P, Ruiz I, Varela MP.
Peripheral embolism y atrial fibrillation: predisposed factors and treatment importance.
XXV Congreso Nacional de la SEMI, Madrid, 5-8 Nov 2002.González-Castillo J, Herreros B, Cubo P, Palacios G, Muñoz S, López N.
Etiologic study of syncopes.
XXV Congreso Nacional de la SEMI, Madrid, 5-8 Nov 2002.Herreros B, Palacios G, Garzarán A, López N, Medrano P, Ruiz I.
Etiology of anaemia without an obvious cause in an internal medicine hospital.
XXV Congreso Nacional de la SEMI, Madrid, 5-8 Nov 2002.Gargantilla P, López N, Herreros B, Garzarán A, Palacios G, Gómez A.
Do we use appropriate doses of medicine?
XXV Congreso Nacional de la SEMI, Madrid, 5-8 Nov 2002.Mubark A, Herreros B, Palacios G, Garzarán A, López N, Díaz A.
Thyroid dysfunction and amiodarone.
XXV Congreso Nacional de la SEMI, Madrid, 5-8 Nov 2002.Herreros B, Santillana T, Gargantilla G, Varela MP, Palacios G, López N.
EEN Study of lung and cardiac pathology.
XXXV Congreso Nacional de la SEPAR, Maspalomas, Gran Canaria, 8-11 Jun 2002.López Barrera N, Garzarán Teijeiro A, Gargantilla Madera P, Herreros Ruiz B, Palacios García G, Gómez García A.
Syncope and electrocardiographic alterations in young patients.
VIII Congreso de la Sociedad Madrid Castilla La Mancha de Medicina Interna, Ciudad Real 15-17 Nov 2001.Sopelana D, Herreros B, Mubarak A, Gómez A, Gargantilla P, González-Castillo J, López N, Garzarán A.
A young patient with tetraparesis in an emergency service.
VIII Congreso de la Sociedad Madrid Castilla La Mancha de Medicina Interna, Ciudad Real 15-17 Nov. 2001.Varela MP, Gómez A, Gargantilla P, Herreros B, Casado J, López N, Lázaro C.
Clinical presentation of abdominal tuberculosis infection in an internal medicine department.
VIII Congreso de la Sociedad Madrid Castilla La Mancha de Medicina Interna, Ciudad Real 15-17 Nov 2001.Herreros B, Palacios G, Gargantilla P, Varela MP, López N, Garzarán A.
Presentation of lung cancer in young patients.
VIII Congreso de la Sociedad Madrid Castilla La Mancha de Medicina Interna, Ciudad Real 15-17 Nov 2001.Courses Up Course of Dislipemias, Author.
http://www.medifusion.com. January 2005.
Collaboration in Clinic Cases Library about Hyperlipemia in speciality care, Author
PharmaConsult Services S.A. October 2004.Extracurricular Courses
Courses in the USA - Illinois Latino Nonprofit Leadership Academy,
Latino Policy Forum, 3 workshop (9 days total), 2012.- The Protection of Human Subjects in Research,
Rush University Medical Center, March 1st, 2008.- Introduction to Epic: Required for all epic users,
Rush University Medical Center, January 23rd, 2008.- HIPPA training,
Rush University Medical Center, March 10th, 2008.-Financial Management of Clinical Trials: What Every Coordinator Should Know, Association of Clinical Research Professionals Webinar, October 10, 2008- Phlebotomy Certification
by Medtexx Medical Corporation, February 9th, 2008- ELI 250 Electrocardiograph Training,
Quintiles ECG Services, October 29th, 2008.- Electrocardiograph Training,
Biomedical System Corporation, April 17th, 2008.- INF 4.5 CRC- Modules,
Phase Forward, June 23rd, 2008.- ADAS certification,
Alzheimer’s Disease Cooperative Study, July 24th, 2008.- ADAS-Cog certification,
i3 Research, July 14th, 2008.- MMSE certification,
i3 Research, July 14th, 2008.- Cantab Training Certification,
Cambridge University, UK, July 21st, 2008- Pfizer Impala Training,
June 25th, 2008.- Hazardous Materials and Dangerous Goods Transportation Training,
Rush Uninversity Medical Center, Chicago, November 15th, 2007.- 2007 Biological Therapeutics for Autoinmune Diseases Symposium,
Northwestern University, Chicago, April 28th, 2007.- Giving and Receiving Feedback,
Rush University Medical Center, Chicago, March 20,2007- Talking about Performance,
Rush University Medical Center, Chicago, March 14th, 2007- Charts and Graphs in Excel and PowerPoint,
Rush University Medical Center, April 26th, 2007- Business-Writing, Grammar and Proofreading II,
Rush University Medical Center, March 13th, 2007.- Tutor training for English as a Second Language,
12 hours, Literacy Works, Chicago, June 9th, 2007.- American English Pronunciation,
Rush University Medical Center, Chicago, May 2nd, 2007- English as a second Language,
Rush University Medical Center, November 13th, 2007.- ESL Advanced Grammar Review,
Rush University Medical Center, October 2nd, 2008Courses in Spain 2005 >Pharmacokinetic interactions in statin therapy.
Formación Médica Continuada. Colegio Médicos de Madrid. Nov.2005 (0.9 cred).
> Contact dermatitis.
Formación Médica Continuada. Colegio Médicos de Madrid. Oct.2005 (0.4 cred).
> New environmental Impact in increased allergic diseases` prevalence.
Formación Médica Continuada. Colegio Médicos de Madrid. Sept.2005 (0.5 cred).
> Practise-Theoretical Course about minor surgery in general practise.
Formación Médica Continuada. Colegio Médicos de Madrid. Sept.2005 (1,5 cred).
> Extra-esophageal manifestations of gastroesophageal reflux.
Formación Médica Continuada. Colegio Médicos de Madrid. March 2005 (1,2 cred).
> Asthma etiology and physiopathology.
Formación Médica Continuada. Colegio Médicos de Madrid. Feb.2005 (0,6 cred).
> Gastroesophageal reflux disease.
Formación Médica Continuada. Colegio Médicos de Madrid. Feb.2005 (2,3 cred).
> Bronchiectasis.
Formación Médica Continuada. Colegio Médicos de Madrid. January. 2005 (0,4 cred).
> Persistance of Drug-Resistance Mutations Acquired During Acute HIV Infection:
A Lesson In Viral Pathogenesis.
School of Medicine. University of Miami.
> Disseminated Intravascular Coagulation (DIC) and AIDS”
School of Medicine. University of Miami.
> Importance of STDs for Society.
School of Medicine. University of Miami.
> Gene Expresión Patterns in HIV and KSHV Infection: Windows into
Pathogenesis.
School of Medicine. University of Miami.
> Transitioning Care of the HIV Patient
School of Medicine. University of Miami.
> HIV/AIDS 2005 Pictorial.
School of Medicine. University of Miami.
> CROI- Update 2005.
School of Medicine. University of Miami.
> 12th Symposium about digest diseases´ the actual treatment.
Digestive Disorders Department. San Carlos Clinic Hospital. Madrid
> 7th Heart Failure Annual Meeting.
Internal Medicine Spanish Society. Santiago de Compostela (Spain). March 2005 3-5.
> Third Course of Clinical electrocardiography.
Instituto Cardiovascular. Hospital Clínico San Carlos. Madrid (Spain). January 2005 17-21..
Internal Medicine Spanish Society. León (Spain).
> Cardiac arrhythmias diagnosis and treatment course.
Comisión de Formación Continuada de las Profesiones Sanitarias de la C. de Madrid.
Madrid (20 hours, 3.7 credits).
> 10th Symposium about oncogenes and cancer.
Cátedra de Oncología Médica de la Facultad de Medicina. Cátedra de Bioq. y Biología
Molecular. Facultad de Farmacia. UCM. Madrid
> Depression: Diagnosis.
Comisión Nacional de Formación Continuada del Sistema Nacional de Salud. Madrid (0,8
credits).
> Depression: Treatment.
Comisión Nacional de Formación Continuada del Sistema Nacional de Salud. Madrid (1,2
credits).
> 11th Symposium about digest diseases´ the actual treatment.
Digestive Disorders Department. San Carlos Clinic Hospital. Madrid.
> 11th Congress of Infectious Diseases and Clinical Microbiology Spanish Society.
Infectious diseases and clinical microbiology Spanish Society.
Bilbao (Spain).
> 27th World Congress of Internal Medicine.
ISIM. Granada (Spain).
Internal Medicine Spanish Society. Córdoba. Spain.
> Dislipemias: Diagnosis and Treatment.
Comisión Nacional de Formación Continuada del Sistema N de Salud. Madrid (60 hours;
4,1 credits).
> Cardiac arrhythmias Treatment.
Cardiac Electrophysiology Department. San Carlos Clinic Hospital. Madrid. (20 hours).
> First Practice Course of Cardiology up-to-date.
Comisión de Formación Continuada. Cardiology Spanish Society. Madrid (12 hours).
> 11th Congress of Madrid-Castilla La Mancha Internal Medicine Society.
Madrid-Castilla La Mancha Internal Medicine Society. Cuenca. Spain.
Comisión Nacional de Formación Continuada del Sist N de Salud. Madrid (5,5 credits)
> 25th National Congress of Internal Medicine Spanish Society.
Internal Medicine Spanish Society. Madrid. Spain.
> 6th EPOC and antimicrobial agents Meeting
Quimiotherapy Spanish Society. Madrid
> 4th Antimicrobial agents Course: clinical practise.
Microbiology Department I. Medicine Faculty. UCM. Madrid (24 hours).
Public Health and Infection Control Spanish Society. Ministerio de Sanidad y Consumo.
Medical Association of Asturias (650 hours).
Medicine Department. Medicine Faculty. Granada University. Granada. Spain.
Instituto de Ciencias Médicas y Jurídicas. Medical Association of Granada. Cons de Salud
Junta de Andalucía. Granada. (30 hours).
Instituto de Ciencias Médicas y Jurídicas. Medical Association of Granada. Cons de Salud
de la Junta de Andalucía. Granada. (30 hours).
> Emergency. Módulo III: VIH+ patient in emergency department.
Intensive Care Unit. Hospital Virgen de las Nieves. Granada.(14 horas).
> First Conference of Intensive Health and Agriculture.
Consejería de Salud Junta Andalucía. Poniente Hospital. El Ejido (Almería)
Intensive Care Unit. Virgen de las Nieves Hospital. Granada (12 hours). 1995 > Emergency Practice Course.
Colegio Mayor Fray Luis de Granada. Universidad de Granada. Granada (20 hours).
> Cardiopulmonary Basic Resuscitation and First Aids.
Training Centre of Spanish Cruz Roja. Granada (32 hours).